These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6867448)

  • 1. [Anti-hepatitis B vaccination with H B VAX and HEVAC B vaccine. Results after the first 3 doses in 2 different risk groups].
    Panichi G; Pescini A; De Bac C; Taliani G; Pezzella M
    Recenti Prog Med; 1983 Jan; 74(1):27-35. PubMed ID: 6867448
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and serological evaluation of preventive vaccination of volunteers of the high risk group with hepatitis B vaccine].
    Brzosko WJ; Laskowski ZK; Bańkowski A; Janicki P; Dabrowa A; Tkacz B; Gall W
    Pol Tyg Lek; 1986 Jul; 41(28):893-5. PubMed ID: 2945170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of vaccine potency against viral hepatitis B performed with HB-vax II vaccine in a group with an increased risk for hepatitis B].
    Leśnik J; Cieślak A; Krychniak E; Sitkiewicz D
    Pol Merkur Lekarski; 1996 Oct; 1(4):249-51. PubMed ID: 9156936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
    Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
    Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine.
    Karpuch J; Scapa E; Eshchar J; Waron M; Bar-Shany S; Shwartz T
    Isr J Med Sci; 1993 Aug; 29(8):449-52. PubMed ID: 8407270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active hepatitis B immunization with an experimental German vaccine. IV. Reactogenicity studies in healthy adults and in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):456-65. PubMed ID: 6485640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination.
    Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW
    Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active immunoprophylaxis of type B viral hepatitis].
    Spiga L; Mela GS
    G Clin Med; 1984; 65(5-6):237-49. PubMed ID: 6236122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.